Michael Hermansson

428 total citations
16 papers, 288 citations indexed

About

Michael Hermansson is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Michael Hermansson has authored 16 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Michael Hermansson's work include Esophageal and GI Pathology (6 papers), Esophageal Cancer Research and Treatment (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Michael Hermansson is often cited by papers focused on Esophageal and GI Pathology (6 papers), Esophageal Cancer Research and Treatment (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Michael Hermansson collaborates with scholars based in Sweden, Denmark and Iceland. Michael Hermansson's co-authors include Thomas Zilling, Jonas Ranstam, Anders Ekedahl, Christer Staël von Holstein, Åsa Sjöling, Lars‐Erik Hansson, Anders Janzon, Ola Winqvist, Malin Hansson and Jenni Adamsson and has published in prestigious journals such as Infection and Immunity, The American Journal of Surgery and Scandinavian Journal of Gastroenterology.

In The Last Decade

Michael Hermansson

12 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hermansson Sweden 8 193 91 79 71 54 16 288
Kuniyasu Irie Japan 11 191 1.0× 20 0.2× 119 1.5× 70 1.0× 61 1.1× 33 281
Aichiro Nobuta Japan 5 305 1.6× 42 0.5× 222 2.8× 62 0.9× 59 1.1× 7 343
J. Bleck Germany 7 169 0.9× 42 0.5× 140 1.8× 50 0.7× 41 0.8× 13 375
Alessandra Carlino Italy 8 323 1.7× 44 0.5× 209 2.6× 151 2.1× 84 1.6× 14 499
Nobuaki Fujikuni Japan 10 134 0.7× 16 0.2× 127 1.6× 50 0.7× 63 1.2× 38 272
Dai Nakamatsu Japan 9 93 0.5× 14 0.2× 93 1.2× 34 0.5× 85 1.6× 50 216
Yu Hatano Japan 10 174 0.9× 28 0.3× 85 1.1× 55 0.8× 14 0.3× 37 270
F.J. Rescorla United States 5 310 1.6× 59 0.6× 37 0.5× 11 0.2× 50 0.9× 6 425
Yoshifumi Nakagawa Japan 11 327 1.7× 26 0.3× 250 3.2× 88 1.2× 85 1.6× 19 439
J Ferwerda Netherlands 7 375 1.9× 43 0.5× 268 3.4× 80 1.1× 40 0.7× 13 475

Countries citing papers authored by Michael Hermansson

Since Specialization
Citations

This map shows the geographic impact of Michael Hermansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hermansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hermansson more than expected).

Fields of papers citing papers by Michael Hermansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hermansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hermansson. The network helps show where Michael Hermansson may publish in the future.

Co-authorship network of co-authors of Michael Hermansson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hermansson. A scholar is included among the top collaborators of Michael Hermansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hermansson. Michael Hermansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rouvelas, Ioannis, Lars Lundell, Maria Nilsson, et al.. (2024). Curative treatment for oligometastatic gastroesophageal cancer– results of a prospective multicenter study. Langenbeck s Archives of Surgery. 410(1). 10–10.
3.
Falkenback, Dan, et al.. (2021). Third time recurrent Boerhaave’s syndrome: a case report. Journal of Medical Case Reports. 15(1). 223–223. 2 indexed citations
4.
Hermansson, Michael, et al.. (2019). The relationship between measures of physical performance in preoperative oesophageal cancer patients. European Journal of Physiotherapy. 23(3). 144–148.
5.
Borg, David, J. Sundberg, Eva Brun, et al.. (2019). Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial. Acta Oncologica. 59(2). 212–218. 4 indexed citations
6.
Walther, Bruno, Christer Staël von Holstein, Thomas Zilling, et al.. (2018). Thoracoabdominal gastrectomy and distal 2/3 esophageal resection with wide lymph node dissection for type II and III adenocarcinoma at the gastro-esophageal junction. The American Journal of Surgery. 218(2). 329–334.
7.
Nilsson, Erik, et al.. (2018). PS02.213: PREDICTING ANASTOMOTIC LEAKAGE AFTER ESOPHAGECTOMY: THE VALUE OF C-REACTIVE PROTEIN. A NATIONWIDE REGISTER STUDY. Diseases of the Esophagus. 31(Supplement_1). 182–182. 1 indexed citations
8.
Kindlund, Bert, Åsa Sjöling, Chakradhar Yakkala, et al.. (2016). CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β. Gastric Cancer. 20(1). 116–125. 69 indexed citations
9.
Hansson, Malin, et al.. (2013). DC-LAMP + Dendritic Cells Are Recruited to Gastric Lymphoid Follicles in Helicobacter pylori-Infected Individuals. Infection and Immunity. 81(10). 3684–3692. 9 indexed citations
10.
Hermansson, Michael & Steven R. DeMeester. (2012). Management of Stage 1 Esophageal Cancer. Surgical Clinics of North America. 92(5). 1155–1167. 7 indexed citations
11.
Hermansson, Michael, Jan Johansson, Tómas Guðbjartsson, et al.. (2010). Esophageal perforation in South of Sweden: Results of surgical treatment in 125 consecutive patients. BMC Surgery. 10(1). 31–31. 41 indexed citations
12.
Hermansson, Michael, Anders Ekedahl, Jonas Ranstam, & Thomas Zilling. (2009). Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974–2002. BMC Gastroenterology. 9(1). 25–25. 63 indexed citations
13.
Quiding‐Järbrink, Marianne, Patrik Sundström, Anna Lundgren, et al.. (2009). Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients. Clinical Immunology. 131(3). 463–471. 22 indexed citations
14.
Hansson, Malin, Michael Hermansson, Helena Svensson, et al.. (2008). CCL28 Is Increased in Human Helicobacter pylori -Induced Gastritis and Mediates Recruitment of Gastric Immunoglobulin A-Secreting Cells. Infection and Immunity. 76(7). 3304–3311. 29 indexed citations
15.
Walther, Charles, Michael Hermansson, & Thomas Zilling. (1999). Does desmopressin reduce bleeding in liver surgery? An experimental study on pigs.. PubMed. 13(1). 83–5. 1 indexed citations
16.
Hermansson, Michael, Christer Staël von Holstein, & Thomas Zilling. (1997). Peptic Ulcer Perforation before and after the Introduction of H2-Receptor Blockers and Proton Pump Inhibitors. Scandinavian Journal of Gastroenterology. 32(6). 523–529. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026